Skip to content

to Explore the Influence of Longitudinal Muscle on the Prognosis of Achalasia Patients After Peroral Endoscopic Myotomy (POEM)

to Explore the Influence of Longitudinal Muscle on the Prognosis of Achalasia Patients After Peroral Endoscopic Myotomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03733756
Enrollment
308
Registered
2018-11-07
Start date
2019-01-01
Completion date
2020-08-31
Last updated
2018-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Achalasia

Brief summary

Achalasia is a disease characterized by lack of peristalsis and lower esophageal sphincter failing to relax. Longitudinal muscle, outer layer of esophageal smooth muscle, is recently found to be responsible for emptying of esophagus for achalasia patients, especially for those type Ⅱcases. Clinical observations also conclude that type Ⅱ achalasia which still preserve longitudinal muscle response best to treatment, among the 3 types. Thus, with high frequent intraluminal ultrasound, clinically applied as endoscopic ultrasound, to measure the function of longitudinal muscle in achalasia patients, the current research aims to explore the influence of longitudinal muscle on the prognosis of achalasia patients after peroral endoscopic myotomy, a routine treatment.

Interventions

PROCEDUREPOEM preserving longitudinal muscle

participants are operated POEM only involving circular muscle, leaving longitudinal muscle intact

PROCEDUREPOEM involving longitudinal muscle

participants are operated POEM involving both circular and longitudinal muscle

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed of esophageal achalasia * Patients or legal surrogates willing and competent to give informed consent

Exclusion criteria

* postoperative or post-POEM * post-pneumatic dilation or post-stenting * fail to go through high frequency intraluminal ultrasound (HFIUS) * Patients with American Society of Anesthesiologists (ASA) score ≥3

Design outcomes

Primary

MeasureTime frameDescription
efficacy of POEM treatment4 weeks after POEMEckardt score ≤3; Eckardt scale includes 4 items: dysphagia, weight loss, poststernal pain and esophageal reflux, each item ranging from 0-3. The higher the score reaches, the more severe the disease is. It is considered to be efficient if the Eckardt score is ≤3 after POEM.

Secondary

MeasureTime frameDescription
complications(GERD) of POEM treatment4 weeks after POEMgastroesophageal reflux disease questionnaire (GERD-Q) score≥2; GERD-Q scale includes 4 items: post-sternal pain, esophageal reflux, proton pump inhibitor applied, endoscopy identified, each item scoring 0 or 1. The higher the score reaches, the more likely the patient has GERD. It is considered to have a complication as GERD if the GERD-Q ≥2.

Countries

China

Contacts

Primary ContactQuan-lin Li, MD
liquanlin321@126.com+86-021-64041990
Backup ContactJia-qi Xu, MD
15221901085@163.com+86-15221901085

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026